Panel rejects calls for routine screening for ovarian cancer, cites role for paclitaxel.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008403:Mass Screening; D010051:Ovarian Neoplasms / Q000517:prevention & control / Q000628:therapy*; D017239:Paclitaxel / Q000008:administration & dosage*
D017239:Paclitaxel; D002945:Cisplatin